Benzinga | Mar 10, 2021 04:10PM EST

Clearside Biomedical Q4 EPS $(0.14) Misses $(0.11) Estimate, Sales $11.00K Miss $1.29M Estimate

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 100 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $11.00 thousand which missed the analyst consensus estimate of $1.29 million by 99.15 percent. This is a 99.43 percent decrease over sales of $1.94 million the same period last year.